FdaApplication
ANDA 212967
Identifiers
- fda_app_no: ANDA212967
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2025-06-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMPHOTERICIN B | AMPHOTERICIN B | 50MG/VIAL | INJECTABLE, LIPOSOMAL;INJECTION |
1 product